ArticleHealth science reports2025

Incretin-Based Therapies in Alzheimer's and Parkinson's Disease: Advancing Neuroprotection With Dual and Triple Agonists-A Review.

Ousman Mohammed et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.